Abstract:The P1 or primary specificity residue of standard mechanism canonical protein inhibitors of serine proteinases, inserts into the S1 primary specificity cavity of the cognate enzyme upon enzyme-inhibitor complex formation. Both natural evolution and protein engineering often change the P1 residue to greatly alter the specificity and the binding strength. To systematize such results we have obtained all 20 coded P1 variants of one such inhibitor, turkey ovomucoid third domain, by recombinant DNA technology. The variants were extensively characterized. The association equilibrium constants were measured at pH 8.30, 21 (±2)°C, for interaction of these variants with six well characterized serine proteinases with hydrophobic S1 cavities. The enzyme names are followed by the best, worst and most specific coded residue for each. Bovine chymotrypsin Aα (Tyr, Pro, Trp), porcine pancreatic elastase (Leu/Ala, Arg, Ala), subtilisin Carlsberg (Cys, Pro, Glu), Streptomyces griseus proteinase A (Cys, Pro, Leu) and B (Cys, Pro, Lys) and human leukocyte elastase (Ile, Asp, Ile). The data set was merged with Ka values for five non-coded variants at P1 of turkey ovomucoid third domain obtained in our laboratory by enzymatic semisynthesis. The ratios of the highest to the lowest Ka for each of the six enzymes range from 106 to 108. The dominant force for binding to these pockets is the hydrophobic interaction. Excess steric bulk (too large for the pocket), awkward shape (Pro, Val and Ile), polarity (Ser) oppose interaction. Ionic charges, especially negative charges on Glu− and Asp− are strongly unfavorable. The Pearson product moment correlations for all the 15 enzyme pairs were calculated. We suggest that these may serve as a quantitative description of the specificity of the enzymes at P1. The sets of Streptomyces griseus proteinases A and B and of the two elastases are strongly positively correlated. Strikingly, chymotrypsin and pancreatic elastase are negatively correlated (−0.10). Such correlations can be usefully extended to many other enzymes and to many other binding pockets to provide a general measure of pocket binding specificity.

Insight to the Residue in P2 Position Prevents the Peptide Inhibitor from Being Hydrolyzed by Serine Proteases

Insights into the serine protease mechanism based on structural observations of the conversion of a peptidyl serine protease inhibitor to a substrate

Cleavage of Peptidic Inhibitors by Target Protease is Caused by Peptide Conformational Transition.

Structural Basis of Specificity of a Peptidyl Urokinase Inhibitor, Upain-1

Elucidation of the Contribution of Active Site and Exosite Interactions to Affinity and Specificity of Peptidylic Serine Protease Inhibitors Using Non-Natural Arginine Analogs.

The Binding Mechanism of A Peptidic Cyclic Serine Protease Inhibitor

Distinctive Binding Modes and Inhibitory Mechanisms of Two Peptidic Inhibitors of Urokinase-Type Plasminogen Activator with Isomeric P1 Residues.

A Cyclic Peptidic Serine Protease Inhibitor: Increasing Affinity by Increasing Peptide Flexibility

Bicyclic Peptide Inhibitor of Urokinase‐Type Plasminogen Activator: Mode of Action

Structural Principles In The Development Of Cyclic Peptidic Enzyme Inhibitors

Design of Specific Serine Protease Inhibitors Based on A Versatile Peptide Scaffold: Conversion of A Urokinase Inhibitor to A Plasma Kallikrein Inhibitor

High-throughput amino acid-level characterization of the interactions of plasminogen activator inhibitor-1 with variably divergent proteases

The Role of His(143) for the Ph-Dependent Stability of Plasminogen Activator Inhibitor-1

Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin

Functional Effects of Single Amino Acid Substitutions in the Region of Phe113 to Asp138 in the Plasminogen Activator Inhibitor 1 Molecule.

Synthesis of a Weak Basic Upa Inhibitor and Crystal Structure of a Complex with Upa

Water-Medicated Specifically Targeting the S1 Pockets among Serine Proteases Using an Arginine Analogue

Selection of High-Affinity Peptidic Serine Protease Inhibitors with Increased Binding Entropy from a Back-Flip Library of Peptide–Protease Fusions

Studies on Amino Acid Replacement and Inhibitory Activity of a Β-Lactamase Inhibitory Peptide

Binding of amino acid side-chains to S1 cavities of serine proteinases

Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres